Lyricare-GM Tablet
Marketer
Urvija Pharmaceuticals
Salt Composition
Gabapentin (300mg) + Methylcobalamin (500mcg)
Overview Lyricare-GM Tablet
Neuropathic pain is effectively managed by Lyricare-GM, a combination medication. Its mechanism involves modulating nerve cell calcium channel activity to reduce pain signals. Lyricare-GM tablets are administered orally, with or without food, ideally before sleep. Maintaining consistent daily dosing ensures therapeutic drug levels. Always adhere to your physician's prescribed dosage and duration. If a dose is missed, take it immediately upon recollection. Complete the entire treatment course, even with symptom improvement. Abrupt cessation should only occur under medical supervision. Common adverse effects include nausea, peripheral swelling, incoordination, blurred vision, fever, and involuntary eye movements (nystagmus). Dizziness and somnolence may occur; avoid activities requiring alertness until the drug's effects are known. Report any unusual mood shifts, new or worsening depression, or suicidal ideation to your doctor. Pregnant, breastfeeding, or planning pregnancy necessitates prior consultation. While generally compatible with other medications, certain drugs (including antacids and alcohol) may interact, increasing adverse event risk.
Primary Ingredients of Lyricare-GM Tablet
No text provided to rephrase.
Uses of Lyricare-GM Tablet
Managing neuropathic pain
Major Benefits of Lyricare-GM Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Swallow the Lyricare-GM Tablet whole; avoid chewing, crushing, or breaking it. This medication can be administered with or without food, though consistent timing is recommended.
Common Side effects of Lyricare-GM Tablet:
- Dizziness
- Sleepiness
- Tiredness
How to use Lyricare-GM Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Lyricare-GM Tablet whole; avoid chewing, crushing, or breaking it. This medication can be taken with or without food, though consistent timing is recommended.
How Lyricare-GM Tablet works:
Lyricare-GM tablets contain gabapentin and methylcobalamin, working synergistically to alleviate neuropathic pain. Gabapentin, an alpha-2-delta calcium channel ligand, reduces pain signals by modulating nerve cell calcium channel activity. Methylcobalamin, a vitamin B12 derivative, supports myelin sheath production and repair, protecting and regenerating nerve fibers. This combined action provides effective relief from nerve damage-related pain.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Lyricare-GM tablets and alcohol may result in significant somnolence.
PregnancyCONSULT YOUR DOCTOR
The use of Lyricare-GM Tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against potential hazards prior to prescribing. Patient consultation with their doctor is advised.
Breast feedingCONSULT YOUR DOCTOR
The use of Lyricare-GM Tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Using Lyricare-GM Tablets might reduce attentiveness, impair vision, or cause drowsiness and dizziness. Driving should be avoided if these effects are experienced.
KidneyCAUTION
Patients with kidney impairment should use Lyricare-GM Tablets judiciously, as dose modification may be necessary. Physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding Lyricare-GM Tablet's use in individuals with hepatic impairment. Physician consultation is advised.
What if you forget to take Lyricare-GM Tablet :
Should you forget a Lyricare-GM Tablet dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Lyricare-GM Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Neuroscience Central Nervous System |



